CSS LLC’s ARK Genomic Revolution ETF ARKG Stock Holding History

CSS LLC’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,000	Closed	-$306K	–	1162
2021 Q4	$306K	Buy	5,000 +2,800	+127%	+$194K	0.01%	814
2021 Q3	$164K	Sell	2,200 -7,800	-78%	-$654K	0.01%	910
2021 Q2	$925K	Sell	10,000 -12,500	-56%	-$1.06M	0.04%	419
2021 Q1	$2M	Sell	22,500 -19,500	-46%	-$1.93M	0.08%	234
2020 Q4	$3.92M	Buy	+42,000	New	+$3.35M	0.15%	112

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

CSS LLC's ARKG Position: Q2 2021 in Review

CSS LLC sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 11,342 shares — an estimated $964K sold.

CSS LLC first reported a position in ARKG in Q4 2020 and held it in 2 quarters. The position peaked at $1.26M in Q4 2020. 512 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

CSS LLC reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
CSS LLC sold 11,342 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $964K.
CSS LLC first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 2 quarters.
CSS LLC's ARK Genomic Revolution ETF position peaked at $1.26M in Q4 2020.
512 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on CSS LLC's 13F filing for Q2 2021, filed 16 Aug 2021.